Le Lézard
Classified in: Health, Science and technology

Genomenon Awarded NIH NHGRI Grant to Curate the Human Genome


ANN ARBOR, Mich., Feb. 15, 2022 /PRNewswire-PRWeb/ -- Genomenon, Inc., an AI-driven genomics company, today announced that it was awarded a $1.7 million grant by the National Institutes of Health (NIH) through the Small Business Innovation Research (SBIR) program. The grant is to accelerate development of the Mastermind® Genomic Search Engine, the company's AI-driven variant interpretation engine, with a vision of curating the entire human genome. The grant enables Genomenon to increase the expertly curated evidence needed for clinicians to make a genetic diagnosis, extending Mastermind beyond its current function as the most complete source of genomic information for medical research.

The NIH's SBIR program focuses on a variety of high-impact technologies spanning research tools, diagnostics, digital health, drugs, and medical devices. It provides funding needed to bring scientific innovations from bench to bedside. Awarded by the NIH's National Human Genome Research Institute, this grant will fund the continued evolution of Genomenon's AI-driven genomic engine, as well as the incorporation of collaborative features for community-based variant interpretation¹.

"Having already curated more than 250 genes for rare diseases and cancer, this NIH funding allows us to accelerate the pace of genetic interpretation for our AI-driven curation engine, which is a crucial first step in a process that enables targeted and efficient use of expert human curators," said Mike Klein, CEO of Genomenon. "Next-generation sequencing gives us the ability to quickly and efficiently create a large amount of genomic data. Curating the entire genome for meaning and actionability at scale is the next step in the evolution of using this information to improve patient care."

Mastermind is the world's most comprehensive source for genomic literature in the variant interpretation space. Used by more than 1,000 diagnostic labs and integrated into 18 clinical-grade decision support platforms and reference databases across the globe, Mastermind connects patient genetic data with critical evidence from scientific literature needed to diagnose rare genetic diseases and cancer.

About Genomenon

Genomenon is an AI-driven genomics company that organizes the world's genomic knowledge to connect patient DNA to scientific research in the diagnosis and development of treatments for patients with rare genetic diseases and cancer.

For more information, visit Genomenon.com
_________________________________________

1. Research reported in this publication was supported by the National Human Genome Research Institute of the National Institutes of Health under Award Number R43HG010446. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Media Contact

Candace Chapman, Genomenon, 1-734-219-5175, [email protected]

 

SOURCE Genomenon


These press releases may also interest you

at 04:43
Jackery, a global top-selling outdoor solar generator brand, has teamed up with actor and outdoors enthusiast Chris Pratt to power outdoor experiences further with the launch of its most advanced green energy product yet, the Jackery Solar Generator...

at 04:39
The vacuum cleaner brand Puppyoo launched a new cordless vacuum product - T11 Mate - in the United States, marking the brand's third household appliance launched in the country. T11 Mate is now available to American consumers through Amazon and...

at 04:30
The "Cell Based Assay & High Content Screening Markets 2022 to 2026: Forecasts by User and Product. With Executive and Consultant Guides. including Customized Forecasting and Analysis. " report has been added to ResearchAndMarkets.com's offering....

at 04:30
The disaster recovery-as-a-service (DRaaS) market size is expected to grow by USD 40.97 bn from 2020 to 2025, according to Technavio. The growth momentum of the market will accelerate at a CAGR of 44.65% during the forecast period. The market's...

at 04:29
Apis Growth Fund II, a private equity fund managed by Apis Partners LLP ("Apis Partners"), a UK-based asset manager that supports growth stage financial services and financial infrastructure businesses, has today announced an investment in DT One, a...

at 04:27
Kurt Sievers, President and Chief Executive Officer of NXP Semiconductors, will deliver the keynote for COMPUTEX 2022 CEO Keynote series. This digital keynote will be on Tuesday May 24, at 2:00 PM (UTC+8), with and will focus on, "Building the...



News published on 15 february 2022 at 00:00 and distributed by: